ScholarIQanswers from OpenAlex & ORCID
Thomas Berger
ResearcherPublications, citations & collaboration network
Thomas Berger is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas Berger have?
ScholarIQindexed works
Thomas Berger has 486 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas Berger have?
ScholarIQcitation count
Thomas Berger has 16,846 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas Berger?
ScholarIQh-index
Thomas Berger has an h-index of 66 in OpenAlex.
What is the i10-index of Thomas Berger?
ScholarIQi10-index
Thomas Berger has an i10-index of 269 in OpenAlex.
What is the ORCID of Thomas Berger?
ScholarIQorcid
The ORCID for Thomas Berger is on the source record.
What is the OpenAlex record for Thomas Berger?
ScholarIQopenalex
The OpenAlex for Thomas Berger is on the source record.
What are the most-cited papers on Thomas Berger?
ScholarIQmost cited works
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Assunta Dal‐Bianco, Günther Grabner, Claudia Kronnerwetter, Michael Weber, Romana Höftberger, Thomas Berger, Eduard Auff, Fritz Leutmezer, Siegfried Trattnig, Hans Lassmann, Francesca Bagnato, Simon Hametner
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuß, Ralf A. Linker, Mathias Mäurer, Orhan Aktaş, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czapliński, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans‐Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding‐Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp, for the ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG)